Azenta Inc (NAS:AZTA)
$ 46.21 -0.9 (-1.91%) Market Cap: 2.11 Bil Enterprise Value: 1.74 Bil PE Ratio: 0 PB Ratio: 1.19 GF Score: 72/100

Azenta Inc at Barclays Global Healthcare Conference Transcript

Mar 15, 2022 / 02:15PM GMT
Release Date Price: $77.31 (+1.32%)
Luke England Sergott
Barclays Bank PLC, Research Division - Research Analyst

Good morning, everybody. My name is Luke Sergott. I cover Life Science Tools and Diagnostics at Barclays. It's my pleasure here to have Lindon from Azenta Life Sciences. And with that, I'll just let you kick off. We're going to do a presentation. There's going to be a couple of Q&A.

Lindon G. Robertson
Azenta, Inc. - Executive VP & CFO

Great. Luke, thank you very much. It's a real pleasure to be here at the Barclays Health Care Conference. And amazingly feels like normal this morning with so many people in the labor conference, so thanks for including us.

With a lot of excitement, we present the Azenta company. Of course, first of all, I'll highlight the safe harbor statement. We'll make some projection comments. And of course, as always, I'm not obligated to update those, but we do frequent communication so I don't think you'll find us hard to read here.

The agenda today, we're going to give you an overview of the business. We launched the company as

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot